An open-label, concentration controlled, randomized, 12 month study of Prograf [tacrolimus] + Rapamune [sirolimus] + cor [corticosteroids]
Phase of Trial: Phase IV
Latest Information Update: 25 Aug 2009
At a glance
- Drugs Corticosteroids; Sirolimus; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Wyeth; Wyeth Pharmaceuticals
- 25 Aug 2009 Actual patient number (484) added as reported by ClinicalTrials.gov.
- 25 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Aug 2009 Actual end date (Jul 2005) added as reported by ClinicalTrials.gov.